AAPS PharmSciTech最新文献

筛选
英文 中文
Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict Pharmacokinetic Endpoints of a Sunscreen Lotion Containing Oxybenzone. 基于生理的药代动力学(PBPK)模型预测含氧苯酮防晒霜的药代动力学终点。
IF 5.1 4区 医学
AAPS PharmSciTech Pub Date : 2026-11-13 DOI: 10.1208/s12249-026-03583-4
Kartik R Roy, Eleftheria Tsakalozou, Lijing Xu, Ann-Marie Afrifa, Apipa Wanasathop, Steven A Adah, Sergio G Coelho, Muhammad Ashraf, Xiaoming Xu, Yang Yang
{"title":"Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict Pharmacokinetic Endpoints of a Sunscreen Lotion Containing Oxybenzone.","authors":"Kartik R Roy, Eleftheria Tsakalozou, Lijing Xu, Ann-Marie Afrifa, Apipa Wanasathop, Steven A Adah, Sergio G Coelho, Muhammad Ashraf, Xiaoming Xu, Yang Yang","doi":"10.1208/s12249-026-03583-4","DOIUrl":"https://doi.org/10.1208/s12249-026-03583-4","url":null,"abstract":"<p><p>Physiologically based pharmacokinetic (PBPK) modeling enables quantitative prediction of pharmacokinetics and pharmacodynamics of drug substances in virtual subjects. Its application to topical drug products, particularly sunscreens, can elucidate drug disposition within the human body, thereby supporting both product development and regulatory decision making. This study involves the development of a PBPK model for a sunscreen lotion containing oxybenzone, a widely used UV filter with documented systemic absorption. The initial PBPK model, parameterized using skin permeation data from in vitro permeation testing (IVPT), underpredicted systemic PK results following a single-dose sunscreen application in the clinical setting. Integrating the product rubbing during application into the refined PBPK model substantially improved model predictability, with prediction errors (%PE) of 19.4 and 16.4 for the geometric mean Cmax and AUC of oxybenzone, respectively. Moreover, the refined model predicted multiple-dose scenarios with %PE values of 7.1 and 6.0 for Cmax and AUC, respectively. Collectively, this study demonstrates a robust PBPK modeling approach that integrates compound properties, formulation attributes, in vitro skin permeation data, and application mechanics to accurately predict systemic oxybenzone exposure. This modeling framework provides an opportunity to support sunscreen safety assessment without extensive clinical studies. Furthermore, it establishes a foundation for PBPK modeling of other topical products where application mechanics meaningfully influence absorption.</p>","PeriodicalId":6925,"journal":{"name":"AAPS PharmSciTech","volume":"27 8","pages":""},"PeriodicalIF":5.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149400894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of Material Grade and Solvent Environment on Thermoresponsive Poloxamer-Based Injectable Hydrogels. 材料等级和溶剂环境对热响应性poloxmer基可注射水凝胶的影响。
IF 5.1 4区 医学
AAPS PharmSciTech Pub Date : 2026-11-13 DOI: 10.1208/s12249-026-03597-y
Marta Tuszynska, Eliza Lewandowska, Joanna Skopinska-Wisniewska, Bartosz Tylkowski, Anna Bajek
{"title":"Influence of Material Grade and Solvent Environment on Thermoresponsive Poloxamer-Based Injectable Hydrogels.","authors":"Marta Tuszynska, Eliza Lewandowska, Joanna Skopinska-Wisniewska, Bartosz Tylkowski, Anna Bajek","doi":"10.1208/s12249-026-03597-y","DOIUrl":"https://doi.org/10.1208/s12249-026-03597-y","url":null,"abstract":"<p><p>Poloxamer 407-based hydrogels are widely used in injectable drug delivery because of their thermoreversible gelation, biocompatibility, and tunable rheological properties. Although commercially available under different trade names, including Kolliphor 407 and Pluronic F127, nominally identical poloxamers may exhibit formulation-dependent differences arising from manufacturing-related variability. Understanding these differences is important for pharmaceutical formulation development. This study compared poloxamer 407 hydrogels prepared from two commercial sources, Kolliphor 407 and Pluronic F127, at concentrations of 10-30% (w/w) in purified water and phosphate-buffered saline (PBS). Formulations were evaluated for gelation temperature, gelation time, and the effect of mixing on thermoresponsive behavior. Mechanical properties were assessed by spreadability and adhesion testing, while pH, in vitro hydrogel dissolution, and cytotoxicity assay using NIH/3T3 fibroblast cells were performed to evaluate material suitability as injectable drug delivery systems. The two commercial grades exhibited distinct formulation characteristics. Kolliphor 407 consistently showed lower gelation temperatures than Pluronic F127 at equivalent concentrations. PBS improved the mechanical properties of Kolliphor 407 formulations, whereas Pluronic F127 was less affected by solvent composition. Cytotoxicity studies demonstrated the superior biocompatibility of PBS-based hydrogels, with 18% formulations showing no significant cytotoxicity compared with controls. Among the tested systems, the 18% Kolliphor 407 hydrogel prepared in PBS demonstrated the most favorable combination of gelation near physiological temperature, appropriate mechanical properties, and excellent biocompatibility. These findings demonstrate that material grade and solvent environment significantly influence the performance of poloxamer 407 formulations despite their nominal chemical equivalence, emphasizing the importance of material selection during the design for potential injectable application.</p>","PeriodicalId":6925,"journal":{"name":"AAPS PharmSciTech","volume":"27 8","pages":""},"PeriodicalIF":5.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149400892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineering a Solid Dispersion-Integrated Fast-Dissolving Oral Film of Nicardipine Hydrochloride for Rapid Delivery in Hypertensive Urgency. 设计一种用于高血压急症快速给药的尼卡地平固体分散集成速溶口服膜。
IF 5.1 4区 医学
AAPS PharmSciTech Pub Date : 2026-11-12 DOI: 10.1208/s12249-026-03594-1
Rutuja Suresh Gadade, Arka Karmakar, Lalit Kumar
{"title":"Engineering a Solid Dispersion-Integrated Fast-Dissolving Oral Film of Nicardipine Hydrochloride for Rapid Delivery in Hypertensive Urgency.","authors":"Rutuja Suresh Gadade, Arka Karmakar, Lalit Kumar","doi":"10.1208/s12249-026-03594-1","DOIUrl":"https://doi.org/10.1208/s12249-026-03594-1","url":null,"abstract":"<p><p>Nicardipine hydrochloride (NCH) is considered an ideal treatment for hypertensive crises, particularly for the management of hypertensive urgency. NCH is a BCS class II drug with limited solubility and exhibits significant first-pass metabolism upon oral administration, which increases the daily dosing frequency. Therefore, the study focuses on developing and evaluating an NCH-solid dispersion (NCHSD) loaded oral fast-dissolving film (OSD-ODF) for the treatment of hypertensive urgency. The NCHSD was prepared by the solvent-casting method using PVP K90 as the carrier at a 1:3 drug-to-carrier ratio. The solubility of NCH was increased by a factor of 23. The NCHSD released 86.0 ± 12.6% of the drug within 6 min. A central composite design was employed to optimize OSD-ODF, with HPMC E6 and PEG 400 concentrations as variables and disintegration time, drug content, weight variation, and tensile strength as responses. A fast disintegration and rapid-release profile were achieved for the optimized ODF with a disintegration time of 88 ± 3.14 s and 104.73 ± 2.00% drug release within 1 min. The in vitro cellular study demonstrated cytocompatibility of optimized ODF in Caco-2 and NIH 3T3 cells. The findings of the cellular permeability study in Caco-2 cells revealed a significant enhancement of the permeability coefficient (p ≤ 0.05) for optimized ODF, about 9 times greater permeability than pure NCH dispersion. This suggests successful development of NCHSD-loaded optimized ODF with better solubility, fast disintegration, rapid release profile, adequate mucoadhesion and biocompatibility. The findings of this work conclude that the prepared OSD-ODF holds excellent potential and is safe for the treatment of hypertensive urgency.</p>","PeriodicalId":6925,"journal":{"name":"AAPS PharmSciTech","volume":"27 8","pages":""},"PeriodicalIF":5.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149400928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ligand-modified Lipid-based Drug Delivery Vehicles for the Selective Targeting of Cancerous Cells. 选择性靶向癌细胞的配体修饰脂质药物递送载体。
IF 5.1 4区 医学
AAPS PharmSciTech Pub Date : 2026-11-12 DOI: 10.1208/s12249-026-03593-2
Chetana Eknure, Maushmi Kumar, Yogeshwar Bachhav
{"title":"Ligand-modified Lipid-based Drug Delivery Vehicles for the Selective Targeting of Cancerous Cells.","authors":"Chetana Eknure, Maushmi Kumar, Yogeshwar Bachhav","doi":"10.1208/s12249-026-03593-2","DOIUrl":"https://doi.org/10.1208/s12249-026-03593-2","url":null,"abstract":"<p><p>Chemotherapy is widely recognized as the mainstay of cancer therapy; however, its lack of specificity and off-target toxicities limit therapeutic success. The lipid-based nanocarriers with targeting ligands such as folic acid, transferrin, aptamers, and antibodies are widely recognized as effective for cancer cell targeting. However, no ligand-modified lipid-based system has reached regulatory approval despite three decades of preclinical development. This review synthesizes and evaluates mechanistic, computational, and translational aspects of ligand-modified lipid nanocarriers. The review discusses lipid drug delivery systems in cancer and targeting strategies, mainly focusing on active targeting by ligands. The ligands are compared against standardized criteria, revealing no single class dominates but rather a balance of competing properties. The enhanced permeability and retention (EPR) effect is examined against clinical evidence. The barriers for ligand-modified lipid-based nanoparticles that can affect the ligand targeting efficiency are discussed. Given the redirected accumulation of LNPs in the liver, which leads to hepatic tropism, approaches such as biomimetics and stealth ligand modification are discussed as strategies to prolong circulation and improve therapeutic efficacy. Furthermore, applications of artificial intelligence to ligand-modified lipid nanoparticles are reviewed, with identification of gaps in application in ligand-modified LNPs. Clinically, FDA- and EMA-approved lipid formulations validate translational feasibility, though ligand-modified systems remain challenging due to manufacturing complexity and regulatory hurdles. This review uniquely integrates mechanistic, translational, and computational perspectives of ligand-modified lipid-based nanoparticle systems to bridge laboratory and preclinical innovation with clinical feasibility in cancer therapeutics.</p>","PeriodicalId":6925,"journal":{"name":"AAPS PharmSciTech","volume":"27 8","pages":""},"PeriodicalIF":5.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149400893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trastuzumab-conjugated Docetaxel-loaded Nanostructured Lipid Carriers for Gastric Cancer. 曲妥珠单抗结合多西他赛负载的纳米结构脂质载体用于胃癌。
IF 5.1 4区 医学
AAPS PharmSciTech Pub Date : 2026-11-12 DOI: 10.1208/s12249-026-03599-w
Ana Camila Marques, Paulo Cardoso da Costa, Sérgia Velho, Maria Helena Amaral
{"title":"Trastuzumab-conjugated Docetaxel-loaded Nanostructured Lipid Carriers for Gastric Cancer.","authors":"Ana Camila Marques, Paulo Cardoso da Costa, Sérgia Velho, Maria Helena Amaral","doi":"10.1208/s12249-026-03599-w","DOIUrl":"https://doi.org/10.1208/s12249-026-03599-w","url":null,"abstract":"<p><p>Gastric cancers overexpressing human epidermal growth factor receptor 2 (HER2) (10-20% of cases) are often associated with aggressive disease and poorer clinical outcomes. Trastuzumab (TZM), a HER2-specific monoclonal antibody, and docetaxel (DTX), a microtubule-stabilizing agent, are established therapies for gastric cancer, with their combination demonstrating efficacy in HER2-positive cases. Nanotechnology enables co-administration of antibodies and drugs, improving control over delivery and prolonging retention within tumors. This study aimed to develop DTX-loaded nanostructured lipid carriers (NLC) covalently conjugated to TZM for local treatment of HER2-positive gastric cancer. Carbodiimide-mediated conjugation was verified by light-scattering and spectroscopic techniques, and the bound antibody was estimated using a colorimetric assay. The conjugated NLC were characterized for their physicochemical properties, stability, drug incorporation, morphology, in vitro release, and in vitro cytotoxicity against AGS (HER2-negative) and NCI-N87 (HER2-positive) cells. The results suggest successful TZM conjugation, yielding stable nanoconjugates that efficiently entrapped the drug and sustained its release. The conjugated DTX-loaded NLC slightly enhanced cytotoxicity in NCI-N87 cells at 10 nM compared with the unconjugated counterparts, but not in AGS cells at any concentration tested. Altogether, these findings point to the potential of the developed nanoconjugate in the context of HER2-positive gastric cancer.</p>","PeriodicalId":6925,"journal":{"name":"AAPS PharmSciTech","volume":"27 8","pages":""},"PeriodicalIF":5.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149400895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eutectic Mixture as a Novel Approach to Improve Compression Properties of Metformin Hydrochloride. 共晶混合物作为改善盐酸二甲双胍压缩性能的新途径。
IF 5.1 4区 医学
AAPS PharmSciTech Pub Date : 2026-11-09 DOI: 10.1208/s12249-026-03600-6
Ramy N Elsergany, Yee Seng Tan, Rajesh S Nair, Paul Chi-Lui Ho, Celine Valeria Liew
{"title":"Eutectic Mixture as a Novel Approach to Improve Compression Properties of Metformin Hydrochloride.","authors":"Ramy N Elsergany, Yee Seng Tan, Rajesh S Nair, Paul Chi-Lui Ho, Celine Valeria Liew","doi":"10.1208/s12249-026-03600-6","DOIUrl":"https://doi.org/10.1208/s12249-026-03600-6","url":null,"abstract":"<p><p>Metformin hydrochloride (MET), an antidiabetic medication, possesses poor compression properties and severe elastic recovery, hindering its formulation via direct compaction. This study engineered MET eutectic mixture and cocrystals using freeze-drying and evaluated them for overcoming these compression liabilities and minimizing punch sticking propensity. Niacinamide (NI), a flexible carboxamide micronutrient beneficial in diabetes management, was evaluated alongside D-Mannitol (MAN), a brittle polyol benchmark excipient, at 1:1 and 1:2 molar ratios. Solid-state characterization (PXRD, FTIR, DSC and TGA) confirmed that both adjuvants yield a eutectic mixture at a 1:1 ratio and a distinct cocrystal phase at a 1:2 ratio. Morphologically, the MET-NI systems exhibited unique layered microstructures. Mechanical profile assessment showed that MET-NI eutectic mixture and cocrystals drastically improved MET plasticity, showing significantly reduced yield pressure via Heckel analysis compared to their corresponding physical mixtures. Consequently, the MET-NI systems displayed enhanced compactibility and tabletability, producing mechanically stable tablets at high drug-coformer loadings (99.5% w/w). Conversely, the MET-MAN formulations exhibited dominant brittle deformation, resulting in severe tablet lamination and capping at compaction pressures exceeding 150 MPa. Furthermore, punch sticking assessment revealed that the enhanced internal tablet strength (API:coformer - API:coformer bonding interaction) of MET-NI eutectics and cocrystals reduced punch sticking mass up to 10-fold compared to the physical mixture. This work demonstrates that particle engineering, particularly utilizing eutectic mixture approach via freeze-drying with flexible carboxamides like niacinamide, presents a highly viable approach for modifying the micromechanical properties of problematic drugs to facilitate seamless large-scale direct compaction manufacturing.</p>","PeriodicalId":6925,"journal":{"name":"AAPS PharmSciTech","volume":"27 8","pages":""},"PeriodicalIF":5.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Semi-Solid Extrusion 3D Printing of Dispersible Oral Dosage Forms: A Mini-Review of Disintegration Determinants. 半固体挤出3D打印分散口服剂型:崩解决定因素的小回顾。
IF 5.1 4区 医学
AAPS PharmSciTech Pub Date : 2026-11-09 DOI: 10.1208/s12249-026-03584-3
Mathis Joly, Noelia M Sanchez-Ballester, Claire Negrell, Sophie Girod Fullana, Ian Soulairol
{"title":"Semi-Solid Extrusion 3D Printing of Dispersible Oral Dosage Forms: A Mini-Review of Disintegration Determinants.","authors":"Mathis Joly, Noelia M Sanchez-Ballester, Claire Negrell, Sophie Girod Fullana, Ian Soulairol","doi":"10.1208/s12249-026-03584-3","DOIUrl":"https://doi.org/10.1208/s12249-026-03584-3","url":null,"abstract":"<p><p>Semi-solid extrusion (SSE) three-dimensional printing (3DP) has become one of the most versatile additive-manufacturing routes for on-demand, personalized oral medicines. Because it processes hydrated polymeric inks at or near room temperature, SSE 3DP is especially attractive for dispersible dosage forms intended for pediatric, geriatric and dysphagic patients. Yet the mechanisms governing the disintegration of SSE-printed forms remain poorly defined and cannot be extrapolated directly from conventionally compressed dispersible tablets, whose cohesion arises from mechanical compaction rather than from a solvent-mediated, hydrogen-bonded network. This mini-review maps the literature published between 2015 and 2025 and critically analyses the manufacturing, formulation and structural-design factors that influence dispersibility. Across the corpus, disintegration is governed primarily by two controllable levers, The formulation composition and the post-printing processing, which together shape the dried polymer network. On this basis, three complementary and non-exclusive disintegration mechanisms are proposed: capillary penetration through the printed micro-architecture, swelling, and erosion or dissolution at interlayer interfaces. Most published formulations still reproduce conventional tablet geometries, thereby under-using the design freedom of 3DP, and quantitative structure-disintegration relationships remain scarce. These gaps define clear priorities for the rational design of the next generation of dispersible SSE-printed medicines.</p>","PeriodicalId":6925,"journal":{"name":"AAPS PharmSciTech","volume":"27 8","pages":""},"PeriodicalIF":5.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical and Device-Independent Assessment of Spatial and Contrast Resolution in X-ray CT. x射线CT空间和对比度分辨率的实用和设备独立评估。
IF 5.1 4区 医学
AAPS PharmSciTech Pub Date : 2026-11-09 DOI: 10.1208/s12249-026-03596-z
Tamaki Miyazaki, Satoshi Iguchi, Kayo Migita, Junichi Sato, Yoshihiro Takeda, Kumiko Kato
{"title":"Practical and Device-Independent Assessment of Spatial and Contrast Resolution in X-ray CT.","authors":"Tamaki Miyazaki, Satoshi Iguchi, Kayo Migita, Junichi Sato, Yoshihiro Takeda, Kumiko Kato","doi":"10.1208/s12249-026-03596-z","DOIUrl":"https://doi.org/10.1208/s12249-026-03596-z","url":null,"abstract":"<p><p>Despite the increasing use of quantitative X-ray computed tomography (XRCT) analysis in pharmaceutical research, practical and device-independent approaches for objectively assessing image quality and defining acquisition conditions remain limited. As image quality in industrial XRCT is largely governed by spatial and contrast resolution, reliable evaluation of these parameters is essential. In this study, a systematic approach was developed for assessing these parameters in XRCT systems commonly used in pharmaceutical research. Most pharmaceutical materials exhibit low X-ray attenuation and limited intrinsic contrast, making reliable assessment of contrast resolution particularly important for quantitative image analysis. Readily available polymer monofilaments and light metal rods were used to evaluate spatial resolution by the 10-90% distance and contrast resolution by the contrast-to-noise ratio (CNR). The 10-90% distance was strongly dependent on CNR and converged to approximately 4-6 times the nominal pixel size with increasing CNR, regardless of imaging system, acquisition conditions, and sample material. Stable and robust spatial resolution measurements required a CNR of approximately 4 or greater. A separation index describing histogram peak separation was highly correlated with CNR (r = 0.9998) across all experimental conditions. Because CNR was proportional to the square root of effective exposure, the proposed approach enabled prediction of the acquisition conditions to achieve a target image quality level. This approach provides a practical and device-independent framework for image quality assessment and optimization of quantitative XRCT measurements.</p>","PeriodicalId":6925,"journal":{"name":"AAPS PharmSciTech","volume":"27 8","pages":""},"PeriodicalIF":5.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scalable Workflow for Extracellular Vesicle Isolation, Purification and Storage Guided by Subtype-Specific Features. 细胞外囊泡分离、纯化和储存的可扩展工作流程,以亚型特异性特征为指导。
IF 5.1 4区 医学
AAPS PharmSciTech Pub Date : 2026-11-09 DOI: 10.1208/s12249-026-03595-0
Zuriñe Erana-Perez, Maria Rossello-Gelabert, Rosa Maria Hernandez, Edorta Santos-Vizcaino
{"title":"Scalable Workflow for Extracellular Vesicle Isolation, Purification and Storage Guided by Subtype-Specific Features.","authors":"Zuriñe Erana-Perez, Maria Rossello-Gelabert, Rosa Maria Hernandez, Edorta Santos-Vizcaino","doi":"10.1208/s12249-026-03595-0","DOIUrl":"https://doi.org/10.1208/s12249-026-03595-0","url":null,"abstract":"<p><p>Extracellular vesicles (EV) are promising drug delivery platforms; however, clinical translation is limited by challenges in scalable production and storage. This study evaluates how isolation, purification, and preservation strategies influence the physicochemical properties, yield, surface composition, and functional cargo of large EV (lEV) and small EV (sEV), using erythropoietin (EPO) as a model therapeutic cargo. EV were isolated by ultracentrifugation (UC) alone or combined with tangential flow filtration (TFF), and stored under - 80°C (reference condition), refrigerated, or lyophilized using a standard (Std Lyo) or a proprietary optimized cycle (Opt Lyo) designed to minimize structural damage without lyoprotectants. Refrigeration reduced particle recovery and altered surface charge in both EV subtypes, indicating decreased stability. Std Lyo induced structural alterations and fragmentation, particularly in sEV, only partially mitigated by trehalose addition. In contrast, Opt Lyo better preserved size distribution and physicochemical stability across subtypes. Both lyophilization cycles altered surface marker detectability, reflecting membrane reorganization. TFF markedly enhanced yield and purity, especially in sEV, but also modified EV composition and their response to Opt Lyo, influencing downstream stability. EPO cargo in lEV showed no significant differences across conditions, with lower mean values after lyophilization, whereas sEV were more sensitive. Uptake assays revealed subtype- and process-dependent differences in cellular internalization, with limited involvement of heparin-sensitive pathways under the tested conditions. Collectively, these findings support a scalable workflow in which TFF-based purification followed by UC and Opt Lyo maximize overall performance, while revealing subtype-specific vulnerabilities that define the final EV product and inform tailored optimization.</p>","PeriodicalId":6925,"journal":{"name":"AAPS PharmSciTech","volume":"27 8","pages":""},"PeriodicalIF":5.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paralleled Polymer Degradation and Oxybutynin Release from Short-Chain Polyesters for In-Situ Forming Intravesical Implant Design. 短链聚酯在原位成形膀胱内植入物设计中的平行聚合物降解和羟布宁释放。
IF 5.1 4区 医学
AAPS PharmSciTech Pub Date : 2026-11-09 DOI: 10.1208/s12249-026-03589-y
Michael Uwe Hartig, Jan Appelhaus, Lukas Felix Crombach, Marc Vollenbröker, Alf Lamprecht
{"title":"Paralleled Polymer Degradation and Oxybutynin Release from Short-Chain Polyesters for In-Situ Forming Intravesical Implant Design.","authors":"Michael Uwe Hartig, Jan Appelhaus, Lukas Felix Crombach, Marc Vollenbröker, Alf Lamprecht","doi":"10.1208/s12249-026-03589-y","DOIUrl":"https://doi.org/10.1208/s12249-026-03589-y","url":null,"abstract":"<p><p>In situ forming implants (ISFI) for intravesical drug delivery represent a promising alternative to current treatment options for neurogenic detrusor overactivity (NDO). Previous formulations demonstrated opportunities for further optimization regarding the temporal alignment between drug release and polymer degradation, which may influence depot persistence during repeated administration. Therefore, different polyester grades with various molecular weights and solvent systems were investigated in order to parallel drug release and polymer degradation. Reducing the molecular weight from 38 to 2 kDa increased degradation threefold (from 8 to 25% within 72 h). Nevertheless, ISFI with PLGA 2 k were characterized by a high initial drug release of 20% after 24 h. By an increase of application frequency from once every nine days to every third day, the initial drug release was reduced to 10% within the first three days paralleling drug release and polymer degradation (10% after 72 h), resulting in a nearly linear relationship between these processes. These findings demonstrate that dose-splitting can effectively modulate release kinetics, supporting improved temporal alignment of drug release and polymer degradation without substantially increasing burst release. In addition, with a low molecular weight polyester grade, depot persistence may be further reduced under repeated administration conditions. Still, an ISFI administered every three days can distinctly improve the quality of life for NDO patients currently administering up to five doses daily.</p>","PeriodicalId":6925,"journal":{"name":"AAPS PharmSciTech","volume":"27 8","pages":""},"PeriodicalIF":5.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书